Loading…
Survey of familial glioma and role of germline p16INK4A/p14ARF and p53 mutation
There is increasing recognition of familial propensity to glioma as a distinct clinical entity beyond a few rare syndromes; however its genetic basis is poorly understood. The role of p16 INK4A /p14 ARF and p53 mutations in sporadic glioma provides a strong rationale for investigating germline mutat...
Saved in:
Published in: | Familial cancer 2010-09, Vol.9 (3), p.413-421 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | There is increasing recognition of familial propensity to glioma as a distinct clinical entity beyond a few rare syndromes; however its genetic basis is poorly understood. The role of
p16
INK4A
/p14
ARF
and
p53
mutations in sporadic glioma provides a strong rationale for investigating germline mutations in these genes as a cause of familial glioma. To survey the familial glioma phenotype and examine the contribution of germline mutation in
p16
INK4A
/p14
ARF
and
p53
to the disease we have analyzed a series of 101 index familial cases collected through the GLIOGENE Consortium (
http://braintumor.epigenetic.org/
). There was little evidence for within family correlations for tumour histology, suggesting generic susceptibility to glial tumors. We did not detect any functional mutations in
p16
INK4A
or
p14
ARF
. One index case with glioblastoma multiforme (GBM) diagnosed at age 54 and had a family history comprised of a paternal aunt with GBM at age 55, carried the
p53
R158H mutation, which is predicted to be functional and has previously been implicated as a cause of Li-Fraumeni syndrome. Our findings provide no evidence that
p16
INK4A
/p14
ARF
and
p53
mutations contribute significantly to familial glioma. |
---|---|
ISSN: | 1389-9600 1573-7292 1573-7292 |
DOI: | 10.1007/s10689-010-9346-5 |